Search Results - "Lanoy, E"

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab by Chaput, N., Lepage, P., Coutzac, C., Soularue, E., Le Roux, K., Monot, C., Boselli, L., Routier, E., Cassard, L., Collins, M., Vaysse, T., Marthey, L., Eggermont, A., Asvatourian, V., Lanoy, E., Mateus, C., Robert, C., Carbonnel, F.

“…Ipilimumab, an immune checkpoint inhibitor targeting CTLA-4, prolongs survival in a subset of patients with metastatic melanoma (MM) but can induce…”
Get full text

Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies by Postel-Vinay, S., Aspeslagh, S., Lanoy, E., Robert, C., Soria, J.-C., Marabelle, A.

“…Immunostimulatory monoclonal antibodies (imAbs) targeting immune checkpoint molecules are revolutionizing oncology not only regarding cancer therapeutics and…”
Get full text

Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival by Delyon, J., Mateus, C., Lefeuvre, D., Lanoy, E., Zitvogel, L., Chaput, N., Roy, S., Eggermont, A.M.M., Routier, E., Robert, C.

“…Ipilimumab is a recently approved immunotherapy that has demonstrated an improvement in the overall survival (OS) of patients with metastatic melanoma. We…”
Get full text

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab by Chaput, N., Lepage, P., Coutzac, C., Soularue, E., Le Roux, K., Monot, C., Boselli, L., Routier, E., Cassard, L., Collins, M., Vaysse, T., Marthey, L., Eggermont, A., Asvatourian, V., Lanoy, E., Mateus, C., Robert, C., Carbonnel, F.

Get full text

Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease by Marthey, L., Mateus, C., Mussini, C., Nachury, M., Nancey, S., Grange, F., Zallot, C., Peyrin-Biroulet, L., Rahier, J. F., Bourdier de Beauregard, M., Mortier, L., Coutzac, C., Soularue, E., Lanoy, E., Kapel, N., Planchard, D., Chaput, N., Robert, C., Carbonnel, F.

“…Background: Therapeutic monoclonal anti-cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) antibodies are associated with immune-mediated enterocolitis. The…”
Get full text

Viral rebound on antiretroviral therapy in France according to region of origin, sex, and HIV acquisition group. Results from the French Hospital Database on HIV ( ANRS CO4 ‐ FHDH ) by Abgrall, S., Selinger‐Leneman, H., Lanoy, E., Becker, A., Matheron, S., de Truchis, P., Pavie, J., Canestri, A., Khuong, M. A., Rey, D., Caby, F., Tattevin, P., Palich, R., Grabar, S.

“…Abstract Background Assessing the potential increased risk of viral rebound (VR) in migrants requires adequate control for sex and acquisition risk groups…”
Get full text

Skin cancers associated with autoimmune conditions among elderly adults by Lanoy, E, Engels, E A

“…Background: Immunosuppression is a risk factor for certain skin cancers. Autoimmune conditions can involve the skin, and may involve immunosuppressive…”
Get full text

Factors influencing quality of life in patients with inherited ichthyosis: a qualitative study in adults using focus groups by Mazereeuw-Hautier, J., Dreyfus, I., Barbarot, S., Serrentino, L., Bourdon-Lanoy, E., Ezzedine, K., Maza, A., Aujoulat, I., Le Rhun, A.

“…Summary Background  There is limited information regarding quality of life in patients with inherited ichthyosis. Objectives  To identify factors influencing…”
Get full text

Short- and medium-term efficacy of specific hydrotherapy in inherited ichthyosis by Bodemer, C., Bourrat, E., Mazereeuw-Hautier, J., Boralevi, F., Barbarot, S., Bessis, D., Blanchet-Bardon, C., Bourdon-Lanoy, E., Stalder, J.-F., Ribet, V., Guerrero, D., Sibaud, V.

“…Summary Background  Management of inherited ichthyoses is symptomatic. Despite treatment, skin symptoms have a major impact on patients’ quality of life (QoL)…”
Get full text

Prediction of Waitlist Mortality in Adult Heart Transplant Candidates: The Candidate Risk Score by Jasseron, C, Legeai, C, Jacquelinet, C, Leprince, P, Cantrelle, C, Audry, B, Lanoy, E, Porcher, R, Bastien, O, Dorent, R

Get full text

Early skin biopsy is helpful for the diagnosis and management of neonatal and infantile erythrodermas by Leclerc-Mercier, S., Bodemer, C., Bourdon-Lanoy, E., Larousserie, F., Hovnanian, A., Brousse, N., Fraitag, S.

“…Background: Erythrodermas are often life‐threatening conditions in infants. Determination of the underlying cause is crucial. Microscopic changes in adult…”
Get full text

319 Risk factors of screen-failures in phase 1 clinical trials by Kempf, E, Lemoine, N, Tergemina-Clain, G, Turpin, A, Postel-Vinay, S, Lanoy, E, Soria, J.C, Hollebecque, A

Get full text

349 Impact of the re-definition of dose-limiting toxicities (DLTs) according to recent recommendations on the DLT rate in phase 1 trials of molecularly targeted agents by Helissey, C, Poterie, A, Massard, C, Hollebecque, A, Paoletti, X, Lanoy, E, Soria, J.C, Postel-Vinay, S

Get full text

3350 Mx1 incomplete loss in primary ulcerated melanoma: An observation that may help explain IFNa sensitivity of ulcerated melanoma? by Flores, C, Tomasic, G, Poirier-Colame, V, Lanoy, E, Cherif-Rebai, K, Robert, C, Zitvogel, L, Eggermont, A

Get full text

Survival after neuroAIDS: Association with antiretroviral CNS Penetration-Effectiveness score by LANOY, E, GUIGUET, M, BENTATA, M, ROUVEIX, E, DHIVER, C, POIZOT-MARTIN, I, COSTAGLIOLA, D, GASNAULT, J

“…We examined if the CNS Penetration-Effectiveness (CPE) score of antiretroviral drugs was associated with survival after a diagnosis of HIV-related…”
Get full text

Nonbacterial purpura fulminans and severe autoimmune acquired protein S deficiency associated with human herpesvirus‐6 active replication by Boccara, O., Lesage, F., Regnault, V., Lasne, D., Dupic, L., Bourdon‐Lanoy, E., Pannier, S., Fraitag, S., Audat, F., Lecompte, T., Hubert, P., Bodemer, C.

“…Summary Nonbacterial purpura fulminans (PF) is rare, usually follows viral infection in young children, and is characterized by specific coagulation disorders,…”
Get full text

Causes of the first AIDS‐defining illness and subsequent survival before and after the advent of combined antiretroviral therapy by Grabar, S, Lanoy, E, Allavena, C, Mary‐Krause, M, Bentata, M, Fischer, P, Mahamat, A, Rabaud, C, Costagliola, D

“…Objectives To analyse the impact of combined antiretroviral treatment (cART) on survival with AIDS, according to the nature of the first AIDS‐defining clinical…”
Get full text

Poor agreement between self-reported and dermatologists' diagnoses for five common dermatoses by Jagou, M., Bastuji-Garin, S., Bourdon-Lanoy, E., Penso-Assathiany, D., Roujeau, J-C.

“…Summary Background  Few epidemiological studies assessing the prevalence of chronic dermatosis are available in France and most of these studies have used…”
Get full text

Awareness, knowledge and attitudes towards sun protection among skin cancer-treated patients in France by Meyer, N, Pruvost-Balland, C, Bourdon-Lanoy, E, Maubec, E, Avri, M-F

“…Background  The incidence of skin cancer has risen over the past years, owing to increased exposure to ultraviolet radiation. Sun protection measures include…”
Get full text

Multiple large solar lentigos on the upper back as clinical markers of past severe sunburn: a case-control study by Derancourt, C, Bourdon-Lanoy, E, Grob, J-J, Guillaume, J-C, Bernard, P, Bastuji-Garin, S

“…Multiple solar lentigos commonly seen on the upper back and shoulders of adults are classically considered as a sign of photodamage, although epidemiological…”
Get more information